CVR: 42057428
Secondary names: DolorestBio ApS
Previous names: DolorestBio ApS
Zyneyro ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named DolorestBio ApS. The management consists of Steen Søren Klysner. The company's owners include Marigold Innovation ApS, IFO ApS and UGether ApS. In 2025, the company reported a gross profit of DKK -4,550,684 and a net result of DKK -7,466,446 compared with DKK 665,931 the year before. Equity amounted to DKK 4,147,370.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er forskning og udvikling af lægemidler, samt dermed beslægtet virksomhed
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
As of May 22, 2026, Marigold Innovation ApS is registered as an owner of Zyneyro ApS with an ownership share of 15%.
As of May 22, 2026, IFO ApS is registered as an owner of Zyneyro ApS with an ownership share of 15%.
As of May 22, 2026, UGether ApS is registered as an owner of Zyneyro ApS with an ownership share of 15%.
As of May 22, 2026, KLMBio ApS is registered as an owner of Zyneyro ApS with an ownership share of 15%.
As of May 22, 2026, Marigold Maturation Fund K/S is registered as an owner of Zyneyro ApS with an ownership share of 20%.
Zyneyro ApS has published its annual report for 2025. Gross profit came to DKK -4,550,684, and the net result was DKK -7,466,446.
As of July 1, 2025, Erik Vinther has joined the board of directors of Zyneyro ApS.
Zyneyro ApS has published its annual report for 2024. Gross profit came to DKK 4,168,667, and the net result was DKK 665,931.
As of May 12, 2025, Revisionsfirmaet Tom Sønderup I/S has stepped down as auditor of Zyneyro ApS.
As of November 1, 2024, Steen Søren Klysner is registered as director of Zyneyro ApS.
As of October 31, 2024, Peter Horn Møller has stepped down as director of Zyneyro ApS.
Zyneyro ApS has published its annual report for 2023. Gross profit came to DKK 1,029,558, and the net result was DKK -34,534.
Zyneyro ApS has published its annual report for 2022. Gross profit came to DKK -27,036, and the net result was DKK -28,481.
As of June 13, 2023, Revisionsfirmaet Tom Sønderup I/S has been appointed auditor of Zyneyro ApS.
As of June 13, 2023, City Administration II ApS has stepped down as auditor of Zyneyro ApS.
On January 3, 2023, the company changed its name from DolorestBio ApS to Zyneyro ApS.
Zyneyro ApS has published its annual report for 2021. Gross profit came to DKK -27,125, and the net result was DKK -29,101.
As of February 15, 2021, Ulrik Gether has joined the board of directors of Zyneyro ApS.
As of February 15, 2021, Kenneth Lindegaard Madsen has joined the board of directors of Zyneyro ApS.
As of February 15, 2021, Peter Horn Møller has left the board of directors of Zyneyro ApS.
As of January 26, 2021, City Administration II ApS has been appointed auditor of Zyneyro ApS.
As of January 26, 2021, Jacob Ørndrup has joined the board of directors of Zyneyro ApS.
As of January 26, 2021, Peter Horn Møller has joined the board of directors of Zyneyro ApS.
As of January 26, 2021, Andreas Toft Sørensen has joined the board of directors of Zyneyro ApS.
As of January 26, 2021, Peter Horn Møller is registered as director of Zyneyro ApS.
Zyneyro ApS was founded on January 26, 2021.
Companies in the same industry and area
CVR 38402056
CVR 39859173
CVR 39880377
CVR 43432583
CVR 43575627
companydata.dk